Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
OCUL
#1782
Ocular Therapeutix, Inc.
8.940
0
-3.14%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.14%
Variazione Mensile
-17.45%
Variazione di 6 mesi
-22.26%
Variazione Annuale
-22.26%
Chiusura Precedente
9.230
0
Open
8.940
0
Bid
Ask
Low
8.940
0
High
8.940
0
Volume
212
Mercati
Mercato Azionario Statunitense
Salute
OCUL
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
157.22 M
159.02 M
159.3 M
174 M
213.05 M
217.69 M
—
Valuation ratios
Enterprise value
940.57 M
965.95 M
817.99 M
1.22 B
2.15 B
1.91 B
6.09 B
Price to earnings ratio
-7.98
-7
-6.6
-7.48
-8.35
-8.55
-30.99
Price to sales ratio
17.58
21.21
19.24
26.57
35.13
43.75
124.69
Price to cash flow ratio
-9.44
-10.04
-8.01
-8.66
-10.39
-11.09
-38.15
Price to book ratio
0.97
4.29
0.88
1.22
1.71
3.47
7.28
Enterprise value to EBITDA ratio
29.65
34.18
-12.88
-20.42
-16.49
-125.77
-175.56
Profitability ratios
Return on assets %
0.07
0.11
0.16
0.15
0.17
0.08
0.56
Return on equity %
0.1
0.15
0.24
0.22
0.27
0.1
0.83
Return on invested capital %
—
—
—
—
—
-557.3
—
Gross margin %
89.88
92.8
88.2
85.56
87.8
87.97
349.53
Operating margin %
298.2
296.06
597.47
502.57
472.35
526.5
2 098.88
EBITDA margin %
16.78
12.9
-588.3
-13.2
-465
-517.09
-1 583.58
Net margin %
236.58
283.25
598.74
503.86
477.3
487.95
2 067.85
Liquidity ratios
Quick ratio
12.94
10.59
10.14
10.02
7.78
15.32
43.26
Current ratio
13.01
10.66
10.22
10.09
7.85
15.39
43.56
Inventory turnover
0.63
0.45
0.4
0.62
0.54
0.45
2.01
Asset turnover
0.03
0.04
0.02
0.03
0.03
0.02
0.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.14
0.15
0.17
0.15
0.17
0.09
0.59
Long term debt to total equity ratio
0.19
0.22
0.26
0.23
0.27
0.11
0.87
Per share metrics
Operating cash flow per share
0.22
0.25
0.26
0.32
0.28
0.29
1.15
EBIT per share
0.01
0.01
-0.38
-0.02
-0.37
-0.37
-1.14
EBITDA per share
0.02
0.01
-0.37
-0.01
-0.37
-0.37
-1.12
Total debt per share
—
—
—
—
—
—
—
Cash per share
2.56
2.48
2.06
2.27
1.87
3.94
10.14
Net current asset value per share
2.83
2.79
2.29
2.51
2.1
4.18
11.08
Tangible book value per share
2.11
1.99
1.57
1.77
1.4
3.49
8.24
Working capital per share
2.61
2.53
2.06
2.26
1.84
3.91
10.07
Book value per share
2.11
1.99
1.57
1.77
1.4
3.49
8.24
Notizie
Il CSO di Ocular Therapeutix Heier vende azioni per 25mila dollari
Il Chief Development Officer di Ocular Therapeutix Kaiser vende azioni per 23.000$
Ocular Therapeutix CSO Heier sells $25k in stock
Ocular Therapeutix chief development officer Kaiser sells $23k in stock
Il CEO di Ocular Therapeutix Dugel vende azioni per 166.000$
Ocular Therapeutix CEO Dugel sells $166k in stock
Il CMO di Ocular Therapeutix Waheed Nadia vende azioni per 27k$
Waheed Nadia, Ocular Therapeutix CMO, sells $27k in stock
Needham riduce il target di prezzo di Ocular Therapeutix dopo i risultati dello studio
Il chief strategy officer di Ocular Therapeutix Nayak vende azioni per 93.000$
Il COO di Ocular Therapeutix Notman vende azioni per 103.471$
Waheed, direttore medico di Ocular Therapeutix, vende azioni per 71.000$